Resilience Further Advances North American Manufacturing Strategy Transformation
·Strengthens end-to-end biologics and sterile drug-product delivery while deepening its commitment to a secure, purpose-driven, single-continent...
NEWS
Read on
Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
Resilience and Lilly expand strategic partnership first established in 2023 Investment will significantly increase U.S. production of Lilly’s...
Resilience Announces Relocation of West Coast Headquarters to Ohio and Expansion of Sterile Manufacturing Capabilities
BLUE ASH, Ohio, June 18, 2026 – Resilience, along with Ohio Governor Mike DeWine, JobsOhio, the City of Blue Ash, and REDI Cincinnati, today...
Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy
New Capital from Oak Hill Advisors to Drive Investment in Go-Forward Manufacturing Operations CINCINNATI--(BUSINESS WIRE)--National Resilience...
Resilience and JobsOhio Announce Continued Partnership and Expansion in Blue Ash
San Diego, CA & Cincinnati, OH – March 26, 2025 – National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to...
Resilience Expands Clinical and Commercial Drug Product Manufacturing Capabilities and Capacities
$225 million to be invested into Cincinnati facility to increase PFS and Cartridge fill/finish capabilities Expanding Research Triangle Park (RTP)...
